Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
Keith J. Sullivan
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
treatment of major depressive disorder
|
| gptkbp:foundedYear |
2003
|
| gptkbp:founder |
Bruce J. Shook
|
| gptkbp:headquartersLocation |
gptkb:Malvern,_Pennsylvania,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Neuronetics
|
| gptkbp:industry |
medical devices
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:product |
NeuroStar Advanced Therapy
|
| gptkbp:specializesIn |
gptkb:transcranial_magnetic_stimulation
|
| gptkbp:stockSymbol |
gptkb:STIM
|
| gptkbp:website |
https://www.neuronetics.com/
|
| gptkbp:bfsParent |
gptkb:NRTX-1001
|
| gptkbp:bfsLayer |
8
|